> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Mylan Recalls 1 Batch of Insulin Pens
- URL: https://www.fdaweb.com/mylan-recalls-1-batch-of-insulin-pens/
- Published: 2022-07-11T12:00:00.000Z
- Updated: 2026-09-14T17:51:23.000Z
- Author: David McFarland
- Tags: Drugs, Devices, #legacy-id-D5152226

Mylan has recalled one batch of insulin glargine (insulin glargine-yfgn) injection in 3mL prefilled pens that are packaged in cartons of five pens. A company [statement](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/mylan-pharmaceuticals-inc-viatris-company-issues-voluntary-nationwide-recall-one-batch-insulin?ref=fdaweb.com) posted by FDA says the recalled product is not the branded Semglee pen but the unbranded insulin glargine-yfgn pens. The batch being recalled was manufactured by Biocon Sdn. Bhd. and distributed by Mylan Specialty in the U.S. between 4/4 and 5/5\. The company says it was recalled due to the potential for the label to be missing from some pens.